Agencies have been tasked to give Bisolvon a fresh approach beyond traditional media advertising as the brand looks to regain its market leading position lost to Solmux, a Unilab product, and Wyeth's Loviscol.
Bisolvon looks for fresh approach
MANILA - Bisolvon, a cough remedy brand from German drugs giant Bohringer Ingelheim, is reviewing its US$1 million advertising account in the Philippines.
Agencies have been tasked to give Bisolvon a fresh approach beyond traditional media advertising as the brand looks to regain its market leading position lost to Solmux, a Unilab product, and Wyeth's Loviscol.